A separate study of 248 cases of breast cancer showed that COX-2 expression was elevated in hormone receptor (HR) negative or human epidermal growth factor receptor 2 (HER2) positive subpopulations and correlated with an activation of the oncogene Akt and with poor survival ( Glover et al., 2011). The gene discussed is ERBB2; the disease is breast carcinoma.